-+ 0.00%
-+ 0.00%
-+ 0.00%
East Asia Pharmaceutical (605177.SH): Trimebutine maleate tablets obtained drug registration certificate
Share
Listen to the news

Zhitong Finance App News, East Asia Pharmaceutical (605177.SH) issued an announcement. Recently, the company received the “Drug Registration Certificate” for trimebutine maleate tablets approved and issued by the State Drug Administration. Trimebutine maleate is a digestive system drug that has the dual regulating effect of promoting insufficient gastric motility or inhibiting excessive gastric motility. Trimebutine maleate tablets can be used to relieve gastrointestinal discomfort such as bloating, abdominal pain, and hiccups caused by chronic gastritis, and treat irritable bowel syndrome.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending